Skip to main content
Signal8
Launch Terminal
Jelinek Richard M profile photo

Richard M. Jelinek

CIK: 0001707429

Transaction Breakdown

Open Market Buys (P)2 (50.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Evolent Health, Inc. logo
EVH

Evolent Health, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

  • Evolent Health, Inc. logo
    EVH

    Evolent Health, Inc.

    Jun 4, 2026
    Award(A)
    Direct
    41.1K shares-
  • Evolent Health, Inc. logo
    EVH

    Evolent Health, Inc.

    Jun 5, 2025
    Award(A)
    Direct
    22K shares-
  • Evolent Health, Inc. logo
    EVH

    Evolent Health, Inc.

    Mar 7, 2025
    Purchase(P)
    Indirect
    15K shares at avg. $9.16$137K
  • Evolent Health, Inc. logo
    EVH

    Evolent Health, Inc.

    Mar 7, 2025
    Purchase(P)
    Indirect
    15K shares at avg. $9.09$136K

1-4 of 4

About Jelinek Richard M

Jelinek Richard M (SEC CIK 0001707429) files insider reports with the SEC as Director of Evolent Health, Inc. (EVH).

Signal8 holds 3 ownership filings by Jelinek Richard M, all Form 4s, filed between Mar 10, 2025 and Jun 8, 2026. Those filings report 4 transactions, from Mar 7, 2025 to Jun 4, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jelinek Richard M's filings is in ARLINGTON, VA.

Recent filings by Jelinek Richard M

  • Jun 4, 2026: Grant or award of EVH shares (Form 4, code A).
  • Jun 5, 2025: Grant or award of EVH shares (Form 4, code A).
  • Mar 7, 2025: Open-market purchases of EVH shares (2 lines, Form 4, code P).

Other insiders filing for Evolent Health, Inc. (EVH)

How to read Form 4 transaction codes